SIX Swiss Exchange eyes life sciences cos for listing

Leading European bourse SIX Swiss Exchange is wooing Indian industrial and life sciences companies to get listed on its platform.
A three-member team is visiting the city to target companies including players in automobile and auto ancillary, pharmaceutical, biotech and medtech, the exchange said in a release.
It said the Swiss financial center and SIX Swiss Exchange hold strong appeal for industrial and life sciences companies.
The exchange with over USD 1,335 billion of free float market capitalisation, representing over 40 per cent of the European market capitalisation of listed life sciences companies and with P/E ratios for industrials (as measured for the year to June 2014) averaging above 18x, has many advantages to offer.

Stating that Switzerland has long-standing tradition in the life science sector, it said Switzerland has the world's highest number per capita of biotech and medtech companies, and it gives listing companies wanting to diversify their investor base the unique advantage of access to the huge Swiss capital market.
"With nearly 60 Industrial companies listed on SIX Swiss Exchange, the industrial sector together with the Financial and Life Sciences industry, is one of the most important industry on our exchange," said Marco Estermann, Head Issuer Relations, SIX Swiss Exchange.
"The Life Sciences industry accounts for approximately one-third of the total market capitalisation of SIX Swiss Exchange. With approximately 43 per cent of the European life sciences market capitalisation, we are the leading European exchange in this sector," he added.